UiPath, Inc. Class A PATH 深 滬
已收盤 02-06 16:00:00 美东时间
12.89
+0.810
+6.71%
華盛通- 最 高12.95
- 今 開12.265
- 成交量 3434.76万股
- 最 低 12.09
- 昨 收 12.08
- 總市值 68.93亿
- 52周最高 19.84
- 市盈率 靜 --
- 換手率 6.42%
- 52周最低 9.38
- 委 比 2.11%
- 總股本 5.35亿
- 歷史最高 90.00
- 量 比 0.99
- 振 幅 7.12%
- 歷史最低 9.38
- 每 手 1
- 風險率 2.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多C3.AI 正洽谈与自动化初创企业Automation Anywhere合并
C3.AI 首席执行官斯蒂芬・埃希基安 据知情人士透露，由科技行业资深人士托马斯・西贝尔创立的 C3.AI 公司，目前正洽谈与私营自动化初创企业 Aut...
01-28 21:01
UiPath CEO and Chairman Daniel Dines Reports Disposal of Common Shares
UiPath CEO and Chairman Daniel Dines Reports Disposal of Common Shares Daniel Dines, CEO and Chairman of UiPath Inc., reported a disposal of common shares of UiPath Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) usin
01-27 05:16
Jim Cramer Says Sell Super Micro — Calls A European Chipmaker 'Cheap And Good'
Jim Cramer recommended selling Super Micro Computer Inc. and doesn't recommend Alkermes plc. Huntington Bancshares is 'terrific.' Smith & Nephew plc should be sold. Cramer also recommends buying Medline Inc. and STMicroelectronics N.V.
01-20 22:02
UiPath Stock Slides As Optimism Meets Harsh Reality
UiPath ( ($PATH) ) has fallen by -16.82%. Read on to learn why. UiPath shares f...
01-17 22:02
Tradr Fires Up High‑Octane 2x ETFs Targeting Rare Earths, AI, Defense
Tradr ETFs launched four 2x leveraged single-stock ETFs targeting rare earths, critical metals, AI automation, and defense-focused stocks.
01-14 00:41
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Maintains Equal-Weight on UiPath, Raises Price Target to $18
Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and raises the price target from $16 to $18.
01-13 04:18
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
RBC Capital Maintains Sector Perform on UiPath, Lowers Price Target to $17
RBC Capital analyst Matthew Hedberg maintains UiPath (NYSE:PATH) with a Sector Perform and lowers the price target from $19 to $17.
01-05 23:57
2026年展望 | 下一轮机会在哪？港美市场四大前沿投资主题曝光！39家精选企业一文速睇
下一轮机会在哪？英伟达、谷歌争相入局，港美市场四大前沿投资主题曝光！39家精选企业一文速睇>>
01-06 11:44
